Vascular Disease and Thrombosis

Science News

CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease
2024 ACC/AHA Clinical Performance and Quality Measures for Adults With Valvular and Structural Heart Disease
Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship
Use of Artificial Intelligence in Improving Outcomes in Heart Disease

Journals

Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes Trial
Loss of Smooth Muscle Tenascin-X Inhibits Vascular Remodeling Through Increased TGF-β Signaling
Glycolytic PFKFB3 and Glycogenic UGP2 Axis Regulates Perfusion Recovery in Experimental Hind Limb Ischemia
Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin‐Resistant Rats: Acute Treatment Versus Long‐Term Protection as an Idiotypic Vaccine for Atherosclerosis
Rapidly Progressive Peripheral Artery Disease: Importance of Oligogenic Inheritance and Functional Validation

Continuing Education

PVD Council members are focused on improving the care of patients with vascular diseases by advancing science, education, advocacy, and improved healthcare delivery. Members support the AHA mission through active involvement in the council’s scientific initiatives and educational programs, including the annual Scientific Sessions and Vascular Discovery meetings.

The ATVB Council focuses on arteriosclerosis, thrombosis and vascular biology. The council advances research, addresses prevention, improves diagnosis and treatment, and works actively with other organizations. It shares reliable information through its annual conference, awards and lectures, and in the AHA’s journal, Arteriosclerosis, Thrombosis, and Vascular Biology.

The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.

The 3CPR Council’s areas of focus encompass integrated cardiopulmonary physiology, critical care, emergency cardiovascular care, and CPR. The council takes a bench-to-bedside and community approach to clinical care, research, and basic science. Pulmonary hypertension and regulation of pulmonary circulation have been topics of ongoing attention.

SAMSON Results

Investigator James Howard, MB, PhD summarizes the results of the SAMSON trial. The trial’s innovative study design sought to identify the root cause of the symptoms contributing to patient nonadherence to statin therapy.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses

Learn more about Professional Membership